Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 84-04-8
2. 1-[3-(2-chlorophenothiazin-10-yl)propyl]piperidine-4-carboxamide
3. Mornidine
4. Nausidol
5. Nometine
6. Pipamazine (inn)
7. 653552fh1n
8. 10-(3-(4-carbamoylpiperidino)propyl)-2-chlorophenothiazine
9. Mometine
10. Pipamazine [inn]
11. Pipamazina
12. Pipamazinum
13. Pipamazine [inn:ban]
14. Pipamazinum [inn-latin]
15. Pipamazina [inn-spanish]
16. Einecs 201-512-9
17. Sc 8016
18. Sc 9387
19. Unii-653552fh1n
20. 1-(3-(3-chlorophenothiazin-10-yl)propyl)-isonipecotamide
21. Pipamazine [mi]
22. Pipamazine [who-dd]
23. Schembl49665
24. Chembl1909072
25. Dtxsid3023477
26. Chebi:135641
27. Isonipecotamide, 1-(3-(2-chlorophenothiazin-10-yl)propyl)-
28. Zinc538183
29. Akos000282635
30. Rp-9153
31. D02606
32. Q7197195
33. 1-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]piperidine-4-carboxamide
| Molecular Weight | 402.0 g/mol |
|---|---|
| Molecular Formula | C21H24ClN3OS |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 401.1328613 g/mol |
| Monoisotopic Mass | 401.1328613 g/mol |
| Topological Polar Surface Area | 74.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 514 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Pipamazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pipamazine, including repackagers and relabelers. The FDA regulates Pipamazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pipamazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pipamazine supplier is an individual or a company that provides Pipamazine active pharmaceutical ingredient (API) or Pipamazine finished formulations upon request. The Pipamazine suppliers may include Pipamazine API manufacturers, exporters, distributors and traders.
Pipamazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pipamazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pipamazine GMP manufacturer or Pipamazine GMP API supplier for your needs.
A Pipamazine CoA (Certificate of Analysis) is a formal document that attests to Pipamazine's compliance with Pipamazine specifications and serves as a tool for batch-level quality control.
Pipamazine CoA mostly includes findings from lab analyses of a specific batch. For each Pipamazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pipamazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pipamazine EP), Pipamazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pipamazine USP).
LOOKING FOR A SUPPLIER?
